Ubiome MEBO study and Bloodtype

MEBO-UBIOME stool DNA study update

Ubiome kindly gave MEBO many Explorer Stool DNA test kits to try and profile our community for this test.

Professor Irene Gabashvili, PhD., MEBO Scientific Director is conducting the MEBO - UBIOME community study on people with METABOLIC MALODOR, other MALODOR types, and PATM.
The full paper will be completed soon.

As it draws to a close Irene can look at the stats and show points of interest.

In Irene's recent AURAMETRIX blog post, Irene has focused on BLOODTYPE among the MEBO community and the world average.

Current MEBO-Ubiome Study participant totals :

Each participant was allowed to get 4 free Ubiome Stool Explorer test kits.
43 returned all samples and completed the questionaire.
8 returned 1 sample.
40+ got kits but didn't do the questionaire.

It's not too late to complete the trial (for those who already signed up).

It's too late for new participants to take part.

Prof Irene's provisional stats on Bloodtype among the MEBO group.

Quote from Irene on the results

The most common blood type in the world is O+ (~36.4%). About 4.3% have blood type O-. Blood types A+, B+ and AB+ are prevalent at approximately 28.3%, 20.6% and 5.1% respectively. Percentages for A-, B- and AB- are 3.5%, 1.4% and 0.5%.
These percentages may differ by country, but it appears that A- and B- blood types are less prevalent in MEBO population, while O and AB are more common.


Symptom-less diet was also different for different blood group types. Average Quality of Life score was 83, 92, 95 and 91 for O, A, B and AB groups, respectively (best for B, then A, worst for O), while MEBO symptoms were also least severe and most controllable for B- type, but worse for those with A antigens. The widest variation in MEBO symptoms was in the AB group.

Irene's full post on her AURAMETRIX blog can be seen here :  Aurametrix Blog Post
 

get New Posts by EMAIL : Enter your email address :

---

A EURORDIS and NORD Member Organization